Q4 2024 Holdings
Filed 2025-02-14 | 39 holdings | $571.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Harrow Health Inc(HROW) | COM | 415858109 | $133.9M | 3,990,000 | 23.4% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $68.0M | 2,260,000 | 11.9% |
| Codexis Inc(CDXS) | COM | 192005106 | $42.2M | 8,840,000 | 7.4% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $38.0M | 2,852,070 | 6.6% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $37.1M | 4,342,500 | 6.5% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $33.6M | 1,625,000 | 5.9% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $28.0M | 500,000 | 4.9% |
| Immunome Inc(IMNM) | COM | 45257U108 | $21.7M | 2,040,000 | 3.8% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $20.0M | 1,698,142 | 3.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $12.8M | 480,000 | 2.2% |
| Ginkgo Bioworks Holdings(DNA) | Class A New | 37611X209 | $11.8M | 1,200,000 | 2.1% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $10.8M | 750,000 | 1.9% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $9.6M | 1,825,000 | 1.7% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $9.5M | 2,317,500 | 1.7% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $8.6M | 400,000 | 1.5% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $8.4M | 325,000 | 1.5% |
| Acelyrin Inc | COM | 00445A100 | $7.2M | 2,235,000 | 1.3% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $7.1M | 378,500 | 1.2% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $6.6M | 250,000 | 1.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $6.1M | 75,000 | 1.1% |
| Gossamer BIO Inc | NOTE 5.000% 6/0 | 38341PAA0 | $6.1M | $11,500,000 | 1.1% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $5.4M | 1,767,500 | 0.9% |
| Biodesix Inc | COM | 09075X108 | $5.3M | 3,465,000 | 0.9% |
| Karyopharm Therapeutics Inc | NOTE 3.000%10/1 | 48576UAA4 | $4.7M | $6,000,000 | 0.8% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $4.6M | 58,500 | 0.8% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $4.1M | 4,490,000 | 0.7% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $4.1M | 105,000 | 0.7% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $4.0M | 2,209,998 | 0.7% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $2.8M | 965,000 | 0.5% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $2.3M | 220,000 | 0.4% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $2.3M | 465,000 | 0.4% |
| Immatics NV(IMTX) | ORDINARY SHARES | N44445109 | $1.2M | 165,000 | 0.2% |
| Ibio Inc(IBIO) | COM NEW | 451033708 | $918.8K | 375,000 | 0.2% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $855.4K | 130,000 | 0.1% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $618.4K | 80,000 | 0.1% |
| Ventyx Biosciences(VTYX) | COM | 92332V107 | $613.2K | 280,000 | 0.1% |
| Pepgen Inc(PEPG) | COM | 713317105 | $416.9K | 110,000 | 0.1% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $275.8K | 25,000 | 0.0% |
| Adagio MED Hldgs Inc(ADGM) | COM | 00534B100 | $116.1K | 110,571 | 0.0% |